Abstract:Hyperphosphorylation of the C-terminal domain (CTD) of the RPB1 subunit of human RNA polymerase (Pol) II is essential for transcriptional elongation and mRNA processing1–3. The CTD contains 52 heptapeptide repeats of the consensus sequence YSPTSPS. The highly repetitive nature and abundant possible phosphorylation sites of the CTD exert special constraints on the kinases that catalyse its hyperphosphorylation. Positive transcription elongation factor b (P-TEFb)—which consists of CDK9 and cyclin T1—is known to hyperphosphorylate the CTD and negative elongation factors to stimulate Pol II elongation1,4,5. The sequence determinant on P-TEFb that facilitates this action is currently unknown. Here we identify a histidine-rich domain in cyclin T1 that promotes the hyperphosphorylation of the CTD and stimulation of transcription by CDK9. The histidine-rich domain markedly enhances the binding of P-TEFb to the CTD and functional engagement with target genes in cells. In addition to cyclin T1, at least one other kinase—DYRK1A6—also uses a histidine-rich domain to target and hyperphosphorylate the CTD. As a low-complexity domain, the histidine-rich domain also promotes the formation of phase-separated liquid droplets in vitro, and the localization of P-TEFb to nuclear speckles that display dynamic liquid properties and are sensitive to the disruption of weak hydrophobic interactions. The CTD—which in isolation does not phase separate, despite being a low-complexity domain—is trapped within the cyclin T1 droplets, and this process is enhanced upon pre-phosphorylation by CDK7 of transcription initiation factor TFIIH1–3. By using multivalent interactions to create a phase-separated functional compartment, the histidine-rich domain in kinases targets the CTD into this environment to ensure hyperphosphorylation and efficient elongation of Pol II.

PAF1C allosterically activates CDK12/13 kinase during RNAPII transcript elongation

RNA Polymerase II–associated Factor 1 Regulates the Release and Phosphorylation of Paused RNA Polymerase II

Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II

Coordinate control of the RNA polymerase II transcription cycle by CDK9-dependent, tripartite phosphorylation of SPT5

The CDK9-SPT5 axis in control of transcription elongation by RNAPII

Activation loop phosphorylation of Cdk11 is restrained by PNUTS-PP1 and regulates Cdk11 activity and function

Distinct Cdk9-phosphatase switches act at the beginning and end of elongation by RNA polymerase II

Sequence and structural determinants of RNAPII CTD phase-separation and phosphorylation by CDK7

Paf1C regulates RNA polymerase II progression by modulating elongation rate

CDK9 keeps RNA polymerase II on track

CDK12 and Integrator-PP2A complex modulates LEO1 phosphorylation for processive transcription elongation

Crosstalk between RNA Pol II C-Terminal Domain Acetylation and Phosphorylation via RPRD Proteins

The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition

Control of the RNA polymerase II phosphorylation state in promoter regions by CTD interaction domain-containing proteins RPRD1A and RPRD1B

Cooperative Interaction of Transcription Termination Factors with the RNA Polymerase II C-terminal Domain.

Pp2b and Pp1 Alpha Cooperatively Disrupt 7sk Snrnp to Release P-Tefb for Transcription in Response to Ca2+ Signaling

The Paf1 complex is required for RNA polymerase II removal in response to DNA damage

PP2B and PP1α cooperatively disrupt 7SK snRNP to release P-TEFb for transcription in response to Ca<sup>2+</sup> signaling

Coordinated regulation of RNA polymerase II pausing and elongation progression by PAF1

Uncoupling the TFIIH Core and Kinase Modules Leads To Misregulated RNA Polymerase II CTD Serine 5 Phosphorylation